Table II.
Whole exon sequencing results of patients with nasopharyngeal carcinoma.
Chromosome | Position (1-based) | Gene name | Original | Mutation | Original (peptide) | Mutation (peptide) | Annotation | P-valuea |
---|---|---|---|---|---|---|---|---|
chr10 | 135440216 | FRG2B | G | A | H | Y | FSHD region gene 2 family member B | 0.87870 |
chr10 | 17147521 | CUBN | G | T | P | T | Cubilin | 0.01335 |
chr1 | 12939765 | PRAMEF4 | A | G | L | P | PRAME family member 4 | 0.00000 |
chr12 | 31242081 | DDX11 | G | A | R | Q | DEAD/H-box helicase 11 | 0.27880 |
chr12 | 8327016 | ZNF705A | T | C | A | T | zinc finger protein 705A | 0.01544 |
chr15 | 102463117 | OR4F4 | T | G | H | P | Olfactory receptor family 4 subfamily F member 4 | 0.49690 |
chr15 | 28197037 | OCA2 | T | C | H | R | OCA2 melanosomaltrans-membrane protein | 0.01397 |
chr15 | 45392075 | DUOX2 | G | A | S | L | Dual oxidase 2 | 0.21210 |
chr15 | 74374822 | GOLGA6A | T | G | H | P | golgin A6 family member A | 0.00665 |
chr16 | 48258198 | ABCC11 | C | T | G | R | ATP binding cassette subfamily C member 11 | 0.07139 |
chr17 | 76433898 | DNAH17 | T | C | H | R | Dyneinaxonemal heavy chain 17 | 0.20260 |
chr17 | 78178893 | CARD14 | C | T | R | W | Caspase recruitment domain family member 14 | 0.07064 |
chr2 | 21231524 | APOB | G | A | P | L | Apolipoprotein B | 0.30960 |
chr2 | 228135631 | COL4A3 | C | T | P | L | Collagen type IV alpha 3 chain | 0.00149 |
chr2 | 87214281 | RGPD1 | T | G | V | G | RANBP2-like and GRIP domain containing 1 | 0.05126 |
chr3 | 172835082 | SPATA16 | C | T | G | E | Spermatogenesis associated 16 | 0.08735 |
chr3 | 37574951 | ITGA9 | G | A | G | E | Integrin subunit alpha 9 | 0.28760 |
chr4 | 120241902 | FABP2 | T | C | T | A | Fatty acid binding protein 2 | 0.03159 |
chr4 | 190881957 | FRG1 | G | T | D | Y | FSHD region gene 1 | 0.05745 |
chr9 | 33386465 | AQP7 | A | G | Y | H | Aquaporin 7 | 0.04698 |
chr9 | 42376286 | ANKRD20A2 | C | T | A | V | Ankyrin repeat domain 20 family member A2 | 0.08193 |
Single nucleotide variations between upward and downward progressing types of nasopharyngeal carcinoma were detected by whole exome sequencing and Genome-Wide Association Studies were used to analyze differential gene expression. P<0.05 was considered as statistically significant.